Community pharmacy compounding-impact on professional status
Related Experiment Video
Updated: Jun 3, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Jennifer Anne Giam1, Andrew J McLachlan, Ines Krass
1Faculty of Pharmacy, The University of Sydney, Pharmacy Building (A15), Sydney, NSW, 2006, Australia. jlee2941@uni.sydney.edu.au
Aim Of The Review:
Extemporaneous compounding has been a core function for pharmacists and was the basis of pharmacy's claim to professional status. The re-emergence of compounding as a specialised practice warrants investigation regarding the influence of this practice on pharmacy's professional status. The aim of this study was to investigate the contribution of extemporaneous compounding to the professional status of pharmacists in community practice.
Method:
A search of the literature was conducted using MEDLINE, EMBASE, IPA, ISI WEB OF KNOWLEDGE, PROQUEST SOCIAL SCIENCE JOURNALS, JSTOR and SOCIOLOGICAL ABSTRACTS databases to identify relevant original research articles, reviews or commentaries.
Results:
Compounding was an important part of pharmacy's claim to professional status. The expansion of the pharmaceutical industry and decline in demand for compounded medications led to a view that pharmacy suffered a loss of professional status. In recent decades patient centred services have been introduced as a reprofessionalisation strategy. Evidence suggests that compounding, as a specialty practice based on a patient centred approach, is increasingly provided in Australia and the United States.
Conclusion:
Compounding has emerged as a specialised area of pharmacy practice in Australia and the United States, and when practiced as a patient centred activity may be a strategy for reprofessionalisation. The extension of compounding beyond mere supply and distribution of a pharmaceutical product to become a platform for development of collaborative professional relationships may also lead to enhanced professional status of pharmacists.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Dosage Regimen: Individualization
